California Pharmaceutical Company
Outcome
OIG enforcement action against California Pharmaceutical Company for false claims, kickbacks, controlled substance. Penalty: $750,000.
Details
California Pharmaceutical Company — OIG Enforcement (2026)
OIG took enforcement action against California Pharmaceutical Company in CA in 2026 involving false claims, kickbacks, controlled substance violations in the Independent Pharmacies sector.
Penalty: $750,000
Violation types: False Claims, Kickbacks, Controlled Substance
Entity type: Pharmacy
Penalty type: Settlement
Location: CA
Source: California Pharmaceutical Company to Pay $750,000 to Resolve False Claims Act Liability for Allegedly Paying Kickbacks to Induce Prescriptions of Opioid Products
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation. Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works